Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 13, 2003. The report primarily details changes in directors' interests in the company's ordinary shares and a specific share repurchase transaction. It does not contain a full financial statement or operational results for a fiscal period.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to specific share transactions:
- Share Repurchase Price: 1,299.5139 pence per share.
- US Retirement Plan ADR Price: Average prices of $41.16 and $41.71 per share.
- Employee Plan Share Price: £12.9035 and £12.90 per share.
Material Changes
The filing reports the following material corporate actions and changes in holdings:
- Share Repurchase: On May 12, 2003, the company purchased 1,100,000 ordinary shares for cancellation at 1,299.5139p per share, utilizing authority granted at the May 20, 2002 Annual General Meeting.
- Directors' Interests:
- Dr. J-P Garnier: Increased interest by 23 Ordinary Share ADRs on May 8, 2003. Additionally, the US Retirement Savings Plan, in which he has a potential interest, saw holdings increase from 18,493,207 to 18,640,540 ADRs between May 8 and May 9, 2003.
- Mr. J.D. Coombe: Acquired 20 Ordinary Shares (10 personal, 10 company match) on May 12, 2003, via the ShareReward Plan.
- Employee Trust Transactions: The GSK Trust transferred or sold various quantities of shares (ranging from 1,802 to 40,673) to participants in employee share option and incentive plans between May 5 and May 9, 2003.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly a regulatory disclosure of share movements and repurchases.
Investor Verification Checklist
- Verify the total number of shares repurchased for cancellation (1,100,000) against the company's authorized buyback limit.
- Confirm the aggregate value of the share repurchase transaction based on the disclosed price of 1,299.5139p.
- Review the total holdings of the US Retirement Savings Plan to understand the scale of the fund's movement (approx. 18.6 million ADRs).
- Check subsequent filings to ensure all director share transactions were properly reported and disclosed.